Fernando Andreu

Chief Executive Officer at

2cureX ApS

62 year

6 connections

Health Technology

Technology Services

Commercial Services

Profile

Fernando Andreu is currently the Chief Executive Officer at 2cureX ApS.
Previously, he held the same position at 2cureX AB from 2021 to 2023.
He was also the Chief Executive Officer at Sysmex Inostics GmbH, Indivumed, Inc., and the Chief Business Officer at Indivumed GmbH.
Mr. Andreu received his undergraduate and MBA degrees from ESADE Business School.

Fernando Andreu active positions

Companies	Position	Start
2cureX ApS 2cureX ApS Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs and technology for the treatment of cancer	Chief Executive Officer	31/12/2020

All active positions of Fernando Andreu

Former positions of Fernando Andreu

Companies	Position	End
2CUREX AB	Chief Executive Officer	28/12/2023
Sysmex Inostics GmbH Sysmex Inostics GmbH Miscellaneous Commercial ServicesCommercial Services Develops advanced genetic testing technologies	Chief Executive Officer	-
Indivumed GmbH Indivumed GmbH Data Processing ServicesTechnology Services Provides data & analytics of clinical bio specimens	Corporate Officer/Principal	-
Indivumed, Inc. Indivumed, Inc. Electronic Equipment/InstrumentsElectronic Technology Founded in 2016, Indivumed, Inc. is a precision oncology biotech company dedicated to developing highly specific cancer therapies targeting unmet medical needs, particularly in colorectal cancer and other solid tumors such as non-small cell lung cancer. The company is based in Frederick, MD. The company leverages a proprietary multi-omics and clinical database, IndivuType, derived from standardized tumor samples collected through its clinical network. This platform integrates molecular, biological, technological, and pharmacological data, supported by advanced biomathematical and bioinformatic analyses and patient-derived tumor models, to identify and validate novel therapeutic targets. Indivumed advances both small molecule and biologic drug candidates through discovery, validation, and IND filing stages, and fosters collaboration via its Onco AI-Med network and research partnerships.	Chief Executive Officer	-

See the detail of Fernando Andreu's experience

Training of Fernando Andreu

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Fernando Andreu's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Indivumed GmbH Indivumed GmbH Data Processing ServicesTechnology Services Provides data & analytics of clinical bio specimens	Technology Services
2cureX ApS 2cureX ApS Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs and technology for the treatment of cancer	Health Technology
Sysmex Inostics GmbH Sysmex Inostics GmbH Miscellaneous Commercial ServicesCommercial Services Develops advanced genetic testing technologies	Commercial Services
2cureX AB 2cureX AB Medical SpecialtiesHealth Technology Develops and supplies in vitro diagnostic (IVD) devices	Health Technology
ESADE Business School ESADE Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Indivumed, Inc. Indivumed, Inc. Electronic Equipment/InstrumentsElectronic Technology Founded in 2016, Indivumed, Inc. is a precision oncology biotech company dedicated to developing highly specific cancer therapies targeting unmet medical needs, particularly in colorectal cancer and other solid tumors such as non-small cell lung cancer. The company is based in Frederick, MD. The company leverages a proprietary multi-omics and clinical database, IndivuType, derived from standardized tumor samples collected through its clinical network. This platform integrates molecular, biological, technological, and pharmacological data, supported by advanced biomathematical and bioinformatic analyses and patient-derived tumor models, to identify and validate novel therapeutic targets. Indivumed advances both small molecule and biologic drug candidates through discovery, validation, and IND filing stages, and fosters collaboration via its Onco AI-Med network and research partnerships.	Electronic Technology